Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oneness Biotech Co's change in inventory for the quarter that ended in Mar. 2026 was $-0.03 Mil. It means Oneness Biotech Co's inventory
increased by $0.03 Mil
from Dec. 2025 to Mar. 2026 .
Oneness Biotech Co's change in inventory for the fiscal year that ended in Dec. 2025 was $-0.17 Mil. It means Oneness Biotech Co's inventory
increased by $0.17 Mil
from Dec. 2024 to Dec. 2025 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Oneness Biotech Co's Days Inventory for the quarter that ended in Mar. 2026 was 339.42.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Oneness Biotech Co's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Oneness Biotech Co's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 3.02.
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Oneness Biotech Co's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oneness Biotech Co Change In Inventory Related Terms
Oneness Biotech Co Change In Inventory Historical Data
* Premium members only.
The historical data trend for Oneness Biotech Co's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oneness Biotech Co Change In Inventory Calculation
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Inventory of $-0.24 Mil mean?
Oneness Biotech Co (LUX:ONEA) has a Change In Inventory of $-0.24 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Oneness Biotech Co and its competitors.
Is Oneness Biotech Co's Change In Inventory too high?
Oneness Biotech Co's current Change In Inventory is $-0.24 Mil. Overall, Oneness Biotech Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Oneness Biotech Co's Change In Inventory compare to VRTX and REGN?
Oneness Biotech Co's Change In Inventory of $-0.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Oneness Biotech Co and its competitors. Oneness Biotech Co's current Change In Inventory is $-0.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneness Biotech Co stock overvalued right now?
Oneness Biotech Co (LUX:ONEA) has a current Change In Inventory of $-0.24 Mil. The stock's GF Value™ is $46.38, compared to a current price of $23.60 — trading 49.1% below its estimated fair value. The current Change In Inventory is $-0.24 Mil. Oneness Biotech Co's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Oneness Biotech Co (LUX:ONEA), the current Change In Inventory is $-0.24 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oneness Biotech Co (LUX:ONEA) Overvalued in 2026?
Based on GuruFocus' analysis, Oneness Biotech Co stock appears to be undervalued.
The current stock price of $23.60 is trading 49.1% below its estimated GF Value™ of $46.38.
Key valuation signals for LUX:ONEA:
Change In Inventory: $-0.24 Mil
GF Value™: $46.38 vs. price of $23.60 (49.1% below fair value)
No single metric tells the full story. See the LUX:ONEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The Group's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and Bonvadis, a wound care medical device. It also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, SNS851, and others. The Group operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation and organic food segment.
56GF Score
Get the complete analysis for LUX:ONEA
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUX:ONEA has been successfully added to your 
